Literature DB >> 20855932

Hypertension is the metabolic syndrome component most strongly associated with microvascular complications and coronary artery calcification in Type 1 diabetes.

T C Rodrigues1, L H Canani, P Schvartzman, J L Gross.   

Abstract

AIM: To evaluate the association of metabolic syndrome (MetS) and its individual components with microvascular complications and coronary artery calcification (CAC) in patients with Type 1 diabetes. MATERIAL/SUBJECTS AND METHODS: Cross-sectional study included 261 patients with Type 1 diabetes. Patients were assessed regarding the presence of MetS according to National Cholesterol Education Program (NCEP) criteria. CAC score was measured in a subset of 100 patients without known cardiovascular disease.
RESULTS: The prevalence of MetS was 13.4% according to the NCEP criteria. Microvascular complications and CAC were more frequent in patients with MetS. In a multiple logistic regression analysis, MetS remained associated with nephropathy [OR: 6.33 (95% CI 2.54-15.77), p<0.001], but not with retinopathy and CAC. Among the MetS components, hypertension was associated with presence of retinopathy [OR: 4.04 (95% CI 1.65- 9.90), p=0.002], nephropathy [OR: 5.92 (95% CI 2.42-14.4), p<0.001] and CAC [OR: 2.97 (95% CI 1.06-8.30), p=0.03].
CONCLUSIONS: Hypertension was the only MetS component associated with retinopathy, nephropathy and the presence of CAC. Hypertension was better associated with CAC than MetS itself.

Entities:  

Mesh:

Year:  2010        PMID: 20855932     DOI: 10.1007/BF03347077

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

1.  Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1976-07       Impact factor: 1.713

2.  Can clinical factors estimate insulin resistance in type 1 diabetes?

Authors:  K V Williams; J R Erbey; D Becker; S Arslanian; T J Orchard
Journal:  Diabetes       Date:  2000-04       Impact factor: 9.461

3.  Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study.

Authors:  K Y Forrest; D J Becker; L H Kuller; S K Wolfson; T J Orchard
Journal:  Atherosclerosis       Date:  2000-01       Impact factor: 5.162

4.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

5.  The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.

Authors:  Georgia Pambianco; Tina Costacou; Trevor J Orchard
Journal:  Diabetes Care       Date:  2007-02-15       Impact factor: 19.112

6.  Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

7.  Serum lipids and the progression of nephropathy in type 1 diabetes.

Authors:  Merlin C Thomas; Milla Rosengård-Bärlund; Vashti Mills; Mats Rönnback; Stephen Thomas; Carol Forsblom; Mark E Cooper; Marja-Riitta Taskinen; Giancarlo Viberti; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

8.  Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology.

Authors:  G Sangiorgi; J A Rumberger; A Severson; W D Edwards; J Gregoire; L A Fitzpatrick; R S Schwartz
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

9.  Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.

Authors:  J Yip; M B Mattock; A Morocutti; M Sethi; R Trevisan; G Viberti
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

10.  The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

Authors:  E Bonora; G Targher; G Formentini; F Calcaterra; S Lombardi; F Marini; L Zenari; F Saggiani; M Poli; S Perbellini; A Raffaelli; L Gemma; L Santi; R C Bonadonna; M Muggeo
Journal:  Diabet Med       Date:  2004-01       Impact factor: 4.359

View more
  7 in total

Review 1.  Hypogonadism and metabolic syndrome.

Authors:  G Corona; G Rastrelli; A Morelli; L Vignozzi; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-06-27       Impact factor: 4.256

Review 2.  Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.

Authors:  John N Stabley; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-22       Impact factor: 8.311

Review 3.  Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis.

Authors:  Rebuma Belete; Zerihun Ataro; Ahmedmenewer Abdu; Merga Sheleme
Journal:  Diabetol Metab Syndr       Date:  2021-03-02       Impact factor: 3.320

4.  Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus.

Authors:  Qianwen Huang; Daizhi Yang; Hongrong Deng; Hua Liang; Xueying Zheng; Jinhua Yan; Wen Xu; Xiangwen Liu; Bin Yao; Sihui Luo; Jianping Weng
Journal:  Diabetes Metab J       Date:  2021-08-31       Impact factor: 5.376

5.  Metabolic syndrome associated with higher glycemic variability in type 1 diabetes: A multicenter cross-sectional study in china.

Authors:  Keyu Guo; Liyin Zhang; Jianan Ye; Xiaohong Niu; Hongwei Jiang; Shenglian Gan; Jian Zhou; Lin Yang; Zhiguang Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

Review 6.  Cardiovascular disease in diabetes, beyond glucose.

Authors:  Robert H Eckel; Karin E Bornfeldt; Ira J Goldberg
Journal:  Cell Metab       Date:  2021-07-21       Impact factor: 31.373

7.  Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis.

Authors:  L L O'Mahoney; N Kietsiriroje; S Pearson; D J West; M Holmes; R A Ajjan; M D Campbell
Journal:  J Endocrinol Invest       Date:  2021-03-17       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.